Lipella Pharmaceuticals (LIPO) announced the completion of dosing for the first cohort in its multi-center Phase 2a clinical trial of LP-310, a liposomal-tacrolimus oral rinse being developed for ...

"This is to inform you that Biocon Pharma Limited, a wholly owned subsidiary of the company, has received approval for Tacrolimus capsule in 0.5mg, 1mg and 5mg strengths, from the ...

[87] Two patients with necrobiosis lipoidica were treated for 8 weeks with 0.1% tacrolimus ointment twice daily; one showed a considerable reduction of the inflammation and regression of the ...

Pharmaceutical company Biocon has received approval from the South African Health Regulatory for its drug Tacrolimus. The Tacrolimus drug will be sold in the form of a capsule. “Biocon Limited ...

Tacrolimus, an immunosuppressant, is used to reduce organ rejection in transplant patients by suppressing the immune system. This approval broadens Biocon’s portfolio of complicated medicinal ...

Glenmark's Tacrolimus Ointment, 0.03%, will be distributed in the U.S. by Glenmark Pharmaceuticals Inc., USA. According to IQVIA TM sales data for the 12-month period ending June 2023 ...

United States, Phoenix, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Glenmark Pharmaceuticals announced that it received final approval from the United States Food and Drug Administration (U.S. FDA) for its 0.03 ...

Aim: Little information is available regarding the influence of CYP3A5 genetic polymorphisms on tacrolimus dose requirement in pediatric liver transplantation. Patients & methods: We performed a ...

New Jersey-based Dr Reddy's Laboratories Inc, a unit of the company, is recalling the affected lot due to the presence of one Tacrolimus 1 mg capsule co-mingled in a bottle containing and labeled ...